celastrol has been researched along with Nerve Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caprioli, J; Gu, L; Kwong, JMK; Piri, N; Yadegari, D; Yu, F | 1 |
| Jantas, D; Konieczny, J; Kuśmierczyk, J; Lasoń, W; Lenda, T; Lorenc-Koci, E; Roman, A | 1 |
2 other study(ies) available for celastrol and Nerve Degeneration
| Article | Year |
|---|---|
The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells.
Topics: Animals; Cell Survival; Disease Models, Animal; Nerve Degeneration; Neuroprotection; Neuroprotective Agents; Ocular Hypertension; Pentacyclic Triterpenes; Rats; Retinal Ganglion Cells; Treatment Outcome; Triterpenes | 2018 |
The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to Parkinson's disease is critically dependent on cell culture conditions.
Topics: Acetylcysteine; Cell Death; Cell Differentiation; Cell Survival; Cells, Cultured; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Drug Interactions; Humans; Nerve Degeneration; Neuroprotective Agents; Parkinson Disease; Pentacyclic Triterpenes; Rotenone; Time Factors; Tretinoin; Triterpenes | 2013 |